SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 17, 2026

KROS

Keros Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago
Insider cluster: 2 insiders, $16K total
Actionable Insight • Neutral

Insider cluster is too small to draw a directional signal. Monitor for any material insider buying from C-suite or larger positions in future filings.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$10.65
T+0 close · Jun 17, 2026 · via day close
Latest settled
+5.26%
T+60 · $11.21
Vs SPY
+3.36%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 18 $10.65entry
  2. T+1 · 5mo ago +3.10%α +3.41% · $10.98
  3. T+5 · 5mo ago −2.25%α −0.59% · $10.41
  4. T+20 · 4mo ago −0.38%α −0.91% · $10.61
  5. T+60 · 2mo ago +5.26%α +3.36% · $11.21
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two KROS directors made minor opposing trades: Bienaime purchased $10K worth of shares while Newton sold $6K. Total insider activity is $16K, less than 0.01% of the $199M market cap, trivial and lacking a clear directional signal.

Key Financial Metrics

Direction
mixed
Total Value
$15.7K
Insiders
2

Key Facts

  • Director Jean Jacques Bienaime purchased 1,000 shares at $10.19 for $10,190 on 2026-06-15.
  • Director Charles W. Newton sold 550 shares at $10.04 for $5,522 on 2026-06-11.
  • Total value of trades is ~$16K, representing ~0.008% of KROS's $199M market cap.
  • Both trades are open-market; no C-suite involvement.

Financial Impact

Trivial insider activity, total $16K across 2 directors, <0.01% of market cap. No material economic signal.

Risk Factors

  • Small sample, only 2 trades.
  • Directors may not be as informed about near-term catalysts as C-suite executives.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
64% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-KROS-1781729786258

Track record

27 reports on KROS

Performance horizon

4 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +12.51% at T+60 after the Jul 30, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Neutral 2/10 Entry $10.03 Now $10.03 −0.00% settles Dec 16
  2. Nov 12, 20264d ago 144 Neutral 2/10 Entry $10.30 Now $10.03 −2.62% settles Dec 14
  3. Nov 5, 202611d ago 8-K Neutral 3/10 Entry $9.36 Now $10.03 +7.16% settles Dec 7
  4. Nov 5, 202611d ago 8-K Neutral 5/10 Entry $9.36 Now $10.03 +7.16% settles Dec 7
  5. Nov 5, 202611d ago Press Release Neutral 5/10 No price data
  6. Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $11.61 Now $10.03 −13.61% settles Nov 25
  7. Sep 29, 20266w ago 8-K Bullish 6/10 Entry $11.19 to $11.43 Now $10.03 −10.37% ▲ +2.10% +1.39% vs SPY
  8. Sep 28, 20267w ago 8-K Neutral 4/10 Entry $11.28 to $11.33 Now $10.03 −11.08% ▲ +0.44% +0.47% vs SPY
  9. Sep 28, 20267w ago Press Release Neutral 3/10 Entry $11.28 to $11.33 Now $10.03 −11.08% ▲ +0.44% +0.47% vs SPY
  10. Sep 17, 20268w ago EFFECT Neutral 3/10 Entry $11.36 to $11.10 Now $10.03 −11.71% ▼ −2.29% −3.49% vs SPY
Showing 10 of 27

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 17, 2026